FdaApplication
ANDA 204922
Identifiers
- fda_app_no: ANDA204922
Properties
| Property | Value |
|---|---|
| applicant_name | AUROLIFE PHARMA LLC |
| application_type | ANDA |
| approval_date | 2016-08-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE; SODIUM BICARBONATE | 40MG;1.1GM | CAPSULE;ORAL |
| OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE; SODIUM BICARBONATE | 20MG;1.1GM | CAPSULE;ORAL |
2 products